Synonyms: Azactam® | Cayston® | Emblaveo® (aztreonam and avibactam) | SQ 26776 | SQ-26776 | SQ26776
aztreonam is an approved drug (FDA (1986), EMA (2009))
Compound class:
Synthetic organic
Comment: Aztreonam is a monocyclic β-lactam antibacterial that is resistant to β-lactamase hydrolysis. It was isolated from Chromobacterium violaceum. Functionally it preferentially binds to and inactivates penicillin-binding protein-3 (PBP-3) and thereby inhibits bacterial cell wall synthesis. Aztreonam was removed from the World Health Organization's List of Essential Medicines in 2019.
|
|
Bioactivity Comments |
Aztreonam is specifically active against aerobic gram-negative bacilli. |